Double‐Blind, Randomized Comparison of the Analgesic and Pharmacokinetic Profiles of Controlled‐ and Immediate‐Release Oral Oxycodone in Cancer Pain Patients
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Thirty patients with cancer pain completed a double‐blind crossover study comparing controlled‐release (CR) and immediate‐release (IR) oxycodone. In open‐label titration (2 to 21 days), these patients were stabilized on IR oxycodone qid. They were then randomized to double‐blind treatment with CR oxycodone q12h or IR oxycodone qid for 3 to 7 days followed by crossover at the same daily dose. Mean (± SD) pain intensity (0 = none to 10= severe) decreased from a baseline of 6.0 ± 2.2 to 2.7 ± 1.1 after titration with IR oxycodone dosed qid. Pain intensity remained stable throughout double‐blind treatment: 2.7 ± 1.9 with CR oxycodone and 2.8 ± 1.9 with IR oxycodone. Acceptability of therapy and pain scores correlated with plasma oxycodone concentrations for each interval and were similar for both medications (IR and CR oxycodone). Adverse events were similar for both formulations. Following repeat dosing under double‐blind conditions, oral CR oxycodone administered q12h provided analgesia comparable to IR oxycodone given qid.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Leow, K. P., Smith, M. T., Williams, B., & Cramond, T. (1992) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1992.176 · Cited by 150
De Broe, M. E., & Elseviers, M. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802123380707 · Cited by 139
Cited by
The Promotion and Marketing of OxyContin: Commercial Triumph, Public Health Tragedy
Van Zee, A. (2009) · American Journal of Public Health · doi:10.2105/ajph.2007.131714 · Cited by 910
Pergolizzi, J., Böger, R. H., Budd, K., Dahan, A., Erdine, S., Hans, G., Kress, H., Langford, R., Likar, R., Raffa, R. B., et al. (2008) · Pain Practice · doi:10.1111/j.1533-2500.2008.00204.x · Cited by 854
The Opioid Epidemic: Crisis and Solutions
Skolnick, P. (2018) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010617-052534 · Cited by 307
Leading the Way to Solutions to the Opioid Epidemic: AOA Critical Issues
Seymour, R. B., Ring, D., Higgins, T., & Hsu, J. R. (2017) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.17.00066 · Cited by 74
Elucidating risk factors for androgen deficiency associated with daily opioid use
Rubinstein, A., & Carpenter, D. M. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.07.015 · Cited by 53
Metadata
- Authors
- Stambaugh, J. E., Reder, R. F., Stambaugh, M. D., Stambaugh, H., & Davis, M.
- Venue
- The Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 2001-05
- Volume
- 41
- Issue
- 5
- Pages
- 500-506
- ISSN
- 0021-9754 (ISSN-L)
- 0091-2700
- 1552-4604
- OpenAlex
- W2122160984
- Cited by
- 67
- References
- 2
- FWCI
- 2.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Double‐Blind, Randomized Comparison of the Analgesic and Pharmacokinetic Profiles of Controlled‐ and Immediate‐Release Oral Oxycodone in Cancer Pain Patients. https://app.cochat.ai/papers/10.1177/00912700122010375
- The paper
- Stambaugh, J. E., Reder, R. F., Stambaugh, M. D., Stambaugh, H., & Davis, M. (2001). Double‐Blind, Randomized Comparison of the Analgesic and Pharmacokinetic Profiles of Controlled‐ and Immediate‐Release Oral Oxycodone in Cancer Pain Patients. The Journal of Clinical Pharmacology. https://doi.org/10.1177/00912700122010375
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.